Blog
21 May, 2025
In order to host the studies, the centres must have the resources and infrastructure. Gregorio Marañón, La Paz, Clínic de Barcelona and Vall d’Hebron are some […]
13 May, 2025
Farmaindustria presents improvements to the Draft Medicines Bill to prepare healthcare for innovation in the next 20 yearsThe future law should promote greater investment in healthcare, […]
12 May, 2025
“It is essential to see medicines and healthcare as an economically and socially very profitable investment for Spain. An investment that generates very important benefits in […]
8 May, 2025
eleconomista.es In 2023, Spain overtook Germany as the country that initiated the most clinical trials and became the European leader. This is reflected in the report […]
22 April, 2025
Joint position on the Draft Bill on Medicines and Health ProductsThe proposed system of price regulation for off-patent medicines puts at risk the supply of medicines […]
8 April, 2025
The International Federation of Innovative Pharmaceutical Industries indicates that the sector invests almost 30% of its revenues in R&D, amounting to nearly 270 billion euros. Diarofarma.com […]
18 March, 2025
The Regional Minister of Health of Cantabria, César Pascual, inaugurates the 25th CAAC-Pharmaindustry Forum. ‘When we work together, not only do we promote research and biomedical […]
6 March, 2025
This research momentum means that one in three new medicines approved by Europe in 2024 was classified as an orphan drug. There are still many untreated […]
4 March, 2025
Getting to know new markets and establishing contacts with both potential customers and potential suppliers. Temperature control in pharmaceutical logistics is one of our pillars, as […]
20 February, 2025
The President of the Government meets for the second time with around twenty representatives of the national, European and global pharmaceutical industry to intensify public-private collaboration […]
13 February, 2025
For the first time, a study by the consultancy firm Afi has evaluated the impact of pharmaceutical companies from a dual perspective: the socio-economic value provided […]
11 February, 2025
37% of all clinical trials being developed in Spain are aimed at treating oncological diseases New drugs are having a direct impact on patient survival, according […]
30 January, 2025
More than 80 pupils from five schools learn about the process of getting medicines to patients: from R&D to clinical trials The “Bringing science to schools” […]
28 January, 2025
The European Medicines Agency approved a total of 114 medicines last year, 46 of which had a new active substance, seven more than the previous year. […]
22 January, 2025
The Coordination Committee of the Technological Platform for Innovative Medicines defines its action plan for 2025 Madrid will host the 18th Annual Conference of Biomedical Research […]
20 January, 2025
Our country is the leader in Europe with 930 clinical studies authorised in 2024. 22% of research to find new drugs is aimed at rare diseases […]
16 January, 2025
The Aemps authorised a total of 930 studies last year, making it the European regulatory agency that approved the most clinical trials, ahead of countries such […]
15 January, 2025
The International Federation of Innovative Pharmaceutical Industry publishes the Facts & Figures 2024 report, which outlines the industry’s contribution globally. In 2023, the industry filed 12,425 […]
20 December, 2024
Pipeline Innovation Review, carried out by the consultancy firm Iqvia for the European Federation of the Pharmaceutical Industry (Efpia) and Vaccines Europe, covers biomedical research underway […]
19 December, 2024
Farmaindustria and Levante-EMV hold a meeting with experts to discuss the creation of the ‘ICAP Guide’ of good practices for the promotion of clinical research in […]
17 December, 2024
The trial, which will evaluate a vaccine under clinical investigation by GSK, will be conducted in Phase I units at La Paz, La Princesa and Puerta […]
5 December, 2024
The percentage of GDP that the state spends on pharmaceuticals has not increased in the last 20 years. Between 2018 and 2023, the increase in the […]
3 December, 2024
The head of Innovation and director of Innovation at Farmaindustria, Miguel González, highlighted how Artificial Intelligence (AI) has brought about a paradigm shift and a revolution […]
20 November, 2024
A report by PwC for the European Federation of the Pharmaceutical Industry shows that the pharmaceutical industry contributes an economic value to the EU of 311,000 […]
18 November, 2024
Farmaindustria presents ‘The pharmaceutical industry and its context in Spain 2024’, the first report that brings together in a single volume all the figures of the […]
15 November, 2024
One year after the presentation of the ‘Guide of good practice recommendations for the promotion of clinical research in primary care’, promoted by Farmaindustria, successful initiatives […]
12 November, 2024
Arantxa Sancho, director of the Department of Medical-Scientific Affairs at Farmaindustria, participates in the informative seminar on pharmacogenomic biomarkers organised by the Aemps. Farmaindustria.es On 29 […]
5 November, 2024
The Farma-Biotech programme facilitates the efficient exchange of information and personal knowledge between research groups, small spin-off companies and the pharmaceutical industry. Since its inception in […]
31 October, 2024
Farmaindustria is leading a project to bring clinical trials to primary care to help decentralise this strategy. laopiniondezamora.es ‘Transforming primary care through clinical trials’ was the […]
29 October, 2024
Assessing Europe’s clinical trial ecosystem, produced by Iqvia for Efpia and Vaccines Europe, shows a 22-12% drop in the share of studies on the continent over […]
5 November, 2025
Advances in nanotechnology, biosensors, and artificial intelligence are redefining drug delivery, with a growing impact on therapeutic efficacy, patient adherence, and global pharmaceutical development. Consalud.es For […]
30 October, 2025
A team from the University of Zurich demonstrates in mice that neural stem cell transplantation regenerates neurons, restores motor functions and opens up a path of […]
29 October, 2025
A SUERF report warns that the tariffs imposed by Washington in 2025 will particularly affect the pharmaceutical sector in Europe, hitting countries such as Ireland, Belgium […]
27 October, 2025
The World Health Organisation explains in an interview with ConSalud.es that the recently launched Global Clinical Trials Forum seeks to combat fragmentation and barriers in research. […]
21 October, 2025
A new report by Analistas Financieros Internacionales (AFi) highlights the sector’s potential to become a global hub for innovation and drug production. Farmaindustria has presented seven […]
14 October, 2025
The president of Farmaindustria, Fina Lladós, calls for a regulatory framework that improves the country’s competitiveness in order to turn the current situation of global uncertainty […]
7 October, 2025
Pharmacists and industry present the updated “Guide to Excellence for Conducting Clinical Trials in Hospital Pharmacy” in Barcelona. This is another step towards excellence and improving […]
2 October, 2025
Our Director of Clinical and Translational Research, Amelia Martín Uranga, participated on Wednesday in Innodata 2025, a national conference on innovation through the use of health […]
30 September, 2025
20minutos.es Spain is bucking the general decline in cancer clinical trials seen across Europe: it is the only country maintaining its level of research, compared to […]
24 September, 2025
Gilead held the 6th Advanced Therapies Meeting to celebrate therapeutic advances in the treatment of lymphoma. consalud.es Advanced therapies are transforming the way we understand and […]
17 September, 2025
Madrid launches a pioneering strategy to become a global benchmark in biopharmaceutical innovation. consalud.es On Monday, the Community of Madrid presented its 2025-2028 Sector Strategy to […]
16 September, 2025
This “fast track” is one of the sector’s strategic measures in the field of biomedical research and is included in the National Pharmaceutical Industry Strategy. Patients […]
